Tenax shareholders reject reverse stock split and stock plan amendment; directors elected

TENAX THERAPEUTICS, INC.

All seven director nominees elected: June Almenoff, Michael Davidson, Declan Doogan, Christopher Giordano, Robyn Hunter, Gerald Proehl, Stuart Rich.
Reverse stock split proposal failed: 5,560,628 for, 5,268,941 against, 112,897 abstain.
Stock incentive plan amendment (increase by 2.75M shares) failed: 2,775,491 for, 4,415,521 against, 262,926 abstain, 3,488,528 broker non-votes.
Ratification of Cherry Bekaert as auditor approved: 9,331,120 for, 1,014,740 against, 596,606 abstain.
Adjournment proposal approved (7,279,249 for) but not used; meeting concluded without adjournment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.